BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16710099)

  • 1. Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.
    Feng Y; Wang Y; Xiong J; Liu Z; Yard B; Lang F
    Kidney Blood Press Res; 2006; 29(2):94-9. PubMed ID: 16710099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
    Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure relationship to nitric oxide, lipid peroxidation, renal function, and renal blood flow in rats exposed to low lead levels.
    Dursun N; Arifoglu C; Süer C; Keskinol L
    Biol Trace Elem Res; 2005 May; 104(2):141-9. PubMed ID: 15894814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats.
    Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS
    J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism mediating hypertension induced by chronic inhibition of nitric oxide synthesis].
    Li X; Yuasa S; Hitomi H; Hashimoto M; Fujioka H; Kiyomoto H; Uchida K; Shoji T; Takahashi N; Matsuo H
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):718-27. PubMed ID: 9396239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
    Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
    Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
    Olzinski AR; McCafferty TA; Zhao SQ; Behm DJ; Eybye ME; Maniscalco K; Bentley R; Frazier KS; Milliner CM; Mirabile RC; Coatney RW; Willette RN
    Cardiovasc Res; 2005 Apr; 66(1):170-8. PubMed ID: 15769460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
    Fernández-Rivas A; García-Estañ J; Vargas F
    J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nitric oxide inhibition on blood pressure depends on rat strain.
    Forster J; Beebe P; Wang H; Wood JG
    J Surg Res; 2001 Apr; 96(2):218-23. PubMed ID: 11266276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis.
    Erley CM; Rebmann S; Strobel U; Schmidt T; Wehrmann M; Osswald H; Risler T
    Exp Nephrol; 1995; 3(5):293-9. PubMed ID: 7583051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
    Anderson S; Chapman JG; Oyama TT; Komers R
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperaldosteronism and altered expression of an SGK1-dependent sodium transporter in ZDF rats leads to salt dependence of blood pressure.
    Resch M; Bergler T; Fredersdorf S; Griese DP; Weil J; Kreuzer P; Brunner S; Riegger GA; Luchner A; Endemann DH
    Hypertens Res; 2010 Oct; 33(10):1082-8. PubMed ID: 20664544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.